Conference Coverage
Conference Coverage
Does first-line pembrolizumab add-on improve PFS in high-risk cervical cancer?
An FDA decision is expected in January on pembrolizumab with concurrent chemoradiotherapy for the first-line treatment of locally advanced...
Conference Coverage
Can some patients with esophageal cancer avoid surgery?
About one-third of patients with esophageal cancer who have a compete response to neoadjuvant chemoradiotherapy may be able to avoid surgery....
Conference Coverage
Adjuvant abemaciclib-ET combo shows long-term benefit in high-risk early breast cancer
Invasive disease–free and distant recurrence–free survival were better with the CDK4/6 inhibitor plus endocrine therapy than endocrine therapy...
Conference Coverage
When to treat DLBCL with radiotherapy?
Choices depend on factors like evidence of disease, radiologists say.
Conference Coverage
Head, neck cancer radiotherapy regimen saves time when resources limited
A randomized controlled trial conducted in low- to middle-income countries showed that 11.5 days could be safely shaved off a conventional...
Conference Coverage
‘Reassuring’ follow-up validates radiation strategy for early breast cancer
At 10 years, partial-breast/reduced-dose therapy are still noninferior to whole-breast approach.
Conference Coverage
Thyroid cancer increase observed in transgender female veterans
“I would characterize the trends in our data as being potentially suggestive or hypothesis generating – not conclusive.”
Conference Coverage
Higher RT doses can boost lifespan, reduce risk of death in LS-SCLC patients
“We need more technical details to understand how to deliver this regimen in clinical practice, and it may not be applicable for all patients.”
Conference Coverage
CT simulation not needed in palliative radiotherapy planning
“Diagnostic CT-based radiation planning substantially reduces time in the [treatment] center without a detriment in plan deliverability or quality...
Conference Coverage
Reducing cognitive impairment from SCLC brain metastases
Stereotactic radiosurgery was better at preventing loss of verbal recall function at 3 months than whole-brain radiation therapy, the current...
Conference Coverage
Short-course SBRT: Standard of care in prostate cancer?
Stereotactic body radiation therapy delivered in five fractions provided similar 5-year disease control as conventional, higher-dose external-beam...